Pneumonia vaccine trial data sends Peninsula biotech stock higher
The company's vaccine would offer protection against 24 varieties of the bacterium responsible for invasive pneumococcal diseases.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: Biotechnology | Health Management | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Vaccines